Navigation Links
Regulus Reports Third Quarter 2013 Financial Results and Recent Highlights
Date:11/13/2013

ells of the liver. Utilizing the GalNAc conjugate chemistry has significantly improved the potency of the active oligonucleotide of RG-101 by achieving targeted delivery of the oligonucleotide to the infected hepatocytes.  Given its attractive properties and positive preclinical profile seen to date, Regulus believes that RG-101 may be an attractive agent to add to existing HCV therapeutic regimens. The Company plans to develop RG-101 as a key component of an HCV combination regimen for patients who have failed, or are intolerant of, the current standard of care and specific patient populations such as HCV/HIV co-infection. Regulus expects to file a regulatory application for RG-101 in the near term and expects to commence clinical studies in man in early 2014. 

About RegulusRegulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is uniquely positioned to leverage a mature therapeutic platform that harnesses the oligonucleotide drug discovery and development expertise of Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., which founded the company.
Regulus has a well-balanced microRNA therapeutic pipeline entering clinical development, an emerging microRNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the microRNA field.  Regulus intends to focus its proprietary efforts on developing microRNA therapeutics for oncology indications and orphan diseases and is currently advancing several programs toward clinical development in oncology, fibrosis and metabolic diseases.  Regulus is also developing RG-101, a GalNAc-conjugated anti-miR targeting microRNA-122, for the treatment of chronic hepatitis C virus infection.  Regulus' commitment to innovation and its l
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
2. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
3. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
4. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
5. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
6. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
7. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
8. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
9. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
10. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
11. Regulus to Present at Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... completed the sale to Galderma of all rights to ... by Valeant for $1.4 billion in cash, pursuant to ... completed its acquisition of Galderma. "We ... to a company that is firmly committed to the ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... Ala., Nov. 9 Surgical Care Affiliates ("SCA") today ... at 11:00 a.m. Eastern Time on Monday, November 16, ... A 30-day replay will be available approximately an ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) ...
... Mass., Nov. 9 Boston Scientific Corporation (NYSE: ... the 38th annual Global Congress for Minimally Invasive Gynecology ... Results from two clinical studies will be presented ... systems and mid-urethral sling systems used to treat pelvic ...
Cached Medicine Technology:Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5
(Date:7/11/2014)... Woodland Hills permanent teeth in one day ... Art Institute in Woodland Hills and Oxnard, Calif., will speak ... Del Rey, Calif. , The award-winning prosthodontist, international speaker ... teeth in one day dental procedure at 1:30 p.m. Friday, ... developed 15 years ago, Dr. Jivraj said. Getting new teeth ...
(Date:7/11/2014)... LENEXA, Kan. (PRWEB) July 11, 2014 B. ... to healthcare providers, has been retained to lead a national ... Health System in Bend, Ore. The top executive ... has recently placed more than 900 healthcare executives into organizations. ... medical providers, St. Charles Health System is the largest provider ...
(Date:7/11/2014)... July 11, 2014 This is ... state of the Cholesterol industry in Global and ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Growing old was thought ... then. However, in recent studies, it was shown that many of ... credence behind them. As it turns out, the elderly can still ... , Of course, with all the time in the world, older ... them to indulge their passions in the twilight of their lives. ...
(Date:7/11/2014)... July 11, 2014 Hands-On ... this August in New York. This ... , -Myofascial Trigger Point Therapy, -Strain ... & Thrust Manipulation, -Neuroobilization & Neurodynamics, -Proprioceptive ... to a single, isolated manual therapy school ...
Breaking Medicine News(10 mins):Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 2Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 3Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 4Health News:Woodland Hills Dental Expert Speaking at Nobel Biocare World Symposium in One Week 5Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 2Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 3Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 2Health News:Cholesterol Industry 2014 Development Trends in Global & China Regions in a New Research Study Available at DeepResearchReports.com 3Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Hands-On Seminars, the Leader in Manual Therapy Continuing Education, Announces Series of Comprehensive Hands-On Training Courses 2
... Oct. 1 Marking a new chapter in the realization ... disabilities, the Training, Education & Research Institute (TERI, Inc.) today ... Center for Research & Life Planning. Set on 20 ... will directly address the crisis of a growing and aging ...
... Renowned orthopaedic and sports medicine surgeon Dr. James Andrews ... taking care of elite professional athletes. However, both organizations ... and new research is now focused on them . ... Sports Medicine in Gulf Breeze, Fla ., founded by ...
... Reportlinker.com announces that a new market research report ... Pharmaceutical Packaging , http://www.reportlinker.com/p0127773/World-Pharmaceutical-Packaging.html , ... Global demand for pharmaceutical packaging will rise 5.3 ... The developed countries of Western Europe, the US and ...
... Scientists from the U.S. Department of Energy,s Lawrence ... uncovered the role played by the least-understood part of ... repair breaks in DNA strands, a process that helps ... the puzzle in place, scientists can better understand how ...
... can have children is one of the major concerns ... fertility can be compromised by cancer treatment. For cancer ... by researchers at Fred Hutchinson Cancer Research Center may ... impact their newborns. The studies, presented as companion papers ...
... the University of Louisville will be the only ... that last week announced they had enabled paralyzed ... Dr. Susan Harkema, the University of Louisville,s ... director at the university,s Kentucky Spinal Cord Injury ...
Cached Medicine News:Health News:Construction Begins on $50 Million Campus for Autism and Developmental Disability Life Quality 2Health News:Construction Begins on $50 Million Campus for Autism and Developmental Disability Life Quality 3Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 2Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 3Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 4Health News:Preventing Injuries in Firefighters Nationwide is New Research Focus for Top Sports Doc James Andrews, M.D. and Athletes' Performance 5Health News:Reportlinker Adds World Pharmaceutical Packaging Report 2Health News:Reportlinker Adds World Pharmaceutical Packaging Report 3Health News:Reportlinker Adds World Pharmaceutical Packaging Report 4Health News:Reportlinker Adds World Pharmaceutical Packaging Report 5Health News:Reportlinker Adds World Pharmaceutical Packaging Report 6Health News:Reportlinker Adds World Pharmaceutical Packaging Report 7Health News:Reportlinker Adds World Pharmaceutical Packaging Report 8Health News:Reportlinker Adds World Pharmaceutical Packaging Report 9Health News:Reportlinker Adds World Pharmaceutical Packaging Report 10Health News:Scientists decipher missing piece of first-responder DNA repair machine 2Health News:Scientists decipher missing piece of first-responder DNA repair machine 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
BD Beaver Chondroplastic blade, sharp on two sides, curved, sterile...
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile....
... accurate testing of large oculomotor ... Fits all standard trial frames. ... of thin optical quality acrylic ... includes a display box. Available ...
Medicine Products: